Brawn Biotech (BOM:530207) Accounts Payable & Accrued Expense : ₹56.7 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech Accounts Payable & Accrued Expense?

Brawn Biotech's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹54.1 Mil) to Dec. 2023 (₹0.0 Mil) but then increased from Dec. 2023 (₹0.0 Mil) to Mar. 2024 (₹56.7 Mil).

Brawn Biotech's annual accounts payable & accrued expense increased from Mar. 2022 (₹44.7 Mil) to Mar. 2023 (₹70.0 Mil) but then declined from Mar. 2023 (₹70.0 Mil) to Mar. 2024 (₹56.7 Mil).

Brawn Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Brawn Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech Accounts Payable & Accrued Expense Chart

Brawn Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

99.94

33.42

44.70

70.04

56.75

Brawn Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															70.04	-	54.11	-	56.75

Brawn Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Brawn Biotech (BOM:530207) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001

Website

https://www.brawnbiotech.com

Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines